Provexis (LON:PXS) Issues Quarterly Earnings Results

Provexis (LON:PXSGet Free Report) issued its quarterly earnings results on Wednesday. The company reported GBX (0.01) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Provexis had a negative net margin of 73.10% and a negative return on equity of 68.68%.

Provexis Trading Down 3.0%

PXS opened at GBX 0.82 on Wednesday. The stock’s 50 day simple moving average is GBX 0.62 and its 200-day simple moving average is GBX 0.67. The stock has a market cap of £19.24 million, a PE ratio of -41.00 and a beta of 1.21. Provexis has a 1 year low of GBX 0.06 and a 1 year high of GBX 0.95.

Provexis Company Profile

(Get Free Report)

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.

Read More

Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.